Access company data including market activity, funding rounds, last funding round price-per-share and valuation milestones. Use proprietary Forge Price data to track performance and monitor how company value changes over time.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| Bidgely | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $87.9M | Series C-1 | 7/25/2023 | $27.51M | $239.86M | $3.59 | CIBC Innovation Banking, Moore Strategic Ventures, Accurant International, Future Energy Ventures, Georgian Partners, Constellation Technology Ventures | |||||
| BioAge | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.42B | Series D | 2/13/2024 | $170M | $440.23M | $3.42 | Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz | |||||
| Cambium | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $127.01M | Series B | 1/5/2026 | $88.76M | $399.01M | $0.54 | 8VC, MVP Ventures, Lockheed Martin Ventures, GSBackers, Veteran Ventures Capital, J17 Ventures, Vanderbilt University, Alumni Ventures, Gaingels, Inevitable Ventures, JACS Capital, Jackson Moses | |||||
| Casana | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $139.73M | Series B | 1/21/2022 | $30M | $323.86M | $12.77 | Morningside, Matrix Partners, General Catalyst, Outsiders Fund | |||||
| Chili Piper | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $51.16M | Series B | 4/15/2021 | $33.16M | $347.07M | $7.39 | Tiger Global Management, Base10 Partners, Gradient Ventures | |||||
| Citizen | Consumer & Lifestyle Consumer Applications | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $146.94M | Series D-2 | 12/20/2024 | $4.37M | $192.18M | $2.59 | Undisclosed Investors | |||||
| Clear Labs | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $157.08M | Series D | 1/13/2025 | $30M | $395.17M | $2.80 | Counterpoint Global, Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, Wing Venture Capital, T. Rowe Price Associates | |||||
| CloudX | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $45.2M | Series A-4 | 6/18/2026 | $15M | $339.88M | $16.12 | Undisclosed Investors | |||||
| Clumio | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $722.05M | Series D | 2/21/2024 | $75M | $151.33M | $0.74 | Sutter Hill Ventures, Index Ventures, Altimeter Capital, NewView Capital | |||||
| Credit Genie | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $56.97M | Series B | 1/28/2025 | $33.79M | $280.53M | $5.97 | Undisclosed Investors | |||||
| CytoVale | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $204.3M | Series D | 10/10/2024 | $101M | $333.35M | $2.77 | Sands Capital, CPP Investments, Norwest Venture Partners, Global Health Investment Corporation, Breakout Ventures, Alumni Ventures | |||||
| data.world | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $192.93M | Series E | 6/20/2025 | $25M | $59.92M | $1.00 | Undisclosed Investors | |||||
| Datameer | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $58.14M | Series II | 7/12/2019 | $40M | $138.6M | $1.00 | Citi Ventures, Kleiner Perkins, Next World Capital, Redpoint Ventures, ST Telemedia, Top Tier Capital Partners | |||||
| Deal.ai | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $40.65M | Series Pre-Seed | 1/22/2026 | $30M | $300M | $17.25 | Impellent Ventures | |||||
| Defined.ai | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $79.41M | Series B-1 | 1/7/2022 | $15M | $347.86M | $9.41 | Undisclosed Investors | |||||
| Digital Reasoning | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $105.26M | Series D-1 | 3/19/2018 | $15M | $343.27M | $2.32 | Barclays, BNP Paribas, Credit Suisse, Goldman Sachs, HCA Management Services, Lemhi Ventures, NASDAQ, Partnership for New York City, Relevance Capital, Square Capital | |||||
| Doceree | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $45.11M | Series B-2 | 9/27/2023 | $7.5M | $271.1M | $104.20 | Creaegis, Eight Roads Ventures, F-Prime Capital | |||||
| EasyKnock | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $141.91M | Series D-1 | 2/29/2024 | $17.07M | $442.42M | $8.90 | Northwestern Mutual | |||||
| Electra Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $302.9M | Series C | 10/22/2025 | $184.13M | $460.97M | $10.15 | Nextech, EQT Life Sciences, Sanofi, HBM Healthcare Investments, Mubadala Capital, OrbiMed, Redmile Group, New Leaf Venture Partners, Westlake BioPartners, Cormorant Asset Management, Blue Owl Capital, RA Capital Management | |||||
| Ellevest | Fintech Other Fintech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $137.21M | Series B | 4/6/2022 | $53M | $364.36M | $6.03 | BMO, Contour Venture Partners, Halogen Ventures, Cleo Capital, New York Ventures of Empire State Development, Stardust Equity, The Venture Collective, Envestnet, Gaingels, Pivotal Ventures, Astia Venture Fund, Khosla, Morningstar, AME Cloud Ventures, Rethink Impact SPV, Salesforce Ventures, PayPal Ventures, Allianz Life Ventures, Elaine Wynn | |||||
| Embroker | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $162.96M | Series D | 12/20/2024 | $18M | $369.84M | $3.66 | Undisclosed Investors | |||||
| Endovascular Engineering | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $141.7M | Series C-2 | 4/7/2026 | $30M | $213.1M | $0.92 | Gilde Healthcare, Norwest, Sante Ventures, 415 Capital, S3 Ventures, Panakes Partners, M&L Healthcare | |||||
| Epic Sciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $606.66M | Series A-3 | 12/29/2023 | $20.9M | $94.14M | $3.00 | Undisclosed Investors | |||||
| Everyrealm | Fintech Blockchain | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $55.66M | Series A | 2/10/2022 | $55.66M | $186.16M | $149.43 | Andreessen Horowitz, Coinbase Ventures, Lightspeed Venture, Dapper Labs, Paris Hilton, Lil Baby, Nas, NGC Ventures, Dragonfly Capital, Liberty City Ventures, Hashed, Animoca Brands, Gene Simmons, Jeffrey Katzenberg, Sebastien Borget, Jeff Zirlin, Wilshare Lane Capital, Pillar VC, Griffin Gaming Partner, Neon, Brevan Howard, Valor Equity Partners, Everblue Management, Galaxy Interactive, GoldenTree Asset Management, Avalanche, Foresight Ventures, Polygon, Anthony Saleh, Andrew Farkas, Gunna, Randi Zuckerberg, Fara Leff, Mario Gotze, Mark Pincus, Lucas Van Cranach, Baby Keem, Lauren Selig, Ebonie Ward, Jonathan Cohen | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.